학술논문
EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Document Type
Abstract
Author
Source
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S195-S196
Subject
Language
ISSN
2531-1379